Drug-related Deaths

Allison Gardner Excerpts

Wednesday 5th November 2025 Commons Chamber

[Charlotte Nichols (Warrington North) (Lab)]

I extend my thanks to Mr Speaker for providing the opportunity to discuss the crucial matter of drug-related deaths. I declare an interest as the unremunerated chair of the Centre for Evidence Based Drug Policy, a think-tank in this policy space. The Office for National Statistics reported last month that deaths related to drug poisonings have increased for the 12th consecutive year, and have consequently reached an all-time high once again. The ONS reports that in 2024, there were 5,565 deaths related to drug poisoning in England and Wales, with just under half of those confirmed to involve an opiate. Continuity is therefore not a strategy; it is a guarantee of further avoidable loss. Every single one of those lives mattered, and every single one of those deaths was preventable.

Eight months ago, a similar debate was held in Westminster Hall on the topic of preventing drug-related deaths, to which the Minister responded. Though it was a well-attended debate, during which Members from across the House called for the expansion of harm reduction and evidence-based measures, I am afraid to say that, since then, limited progress has been made in advancing drugs policy to limit the unspeakable further loss of life in our constituencies.

[Dr Allison Gardner (Stoke-on-Trent South) (Lab)]

Stoke-on-Trent has the highest number of drug-related deaths in north Staffordshire. Synthetic cathinones, colloquially known as monkey dust, are used in Stoke-on-Trent to an extent not seen elsewhere in the country. Does my hon. Friend agree that more needs to be done to battle the scourge of monkey dust in Stoke-on-Trent?

[Charlotte Nichols]

I absolutely agree. There are huge regional disparities in drug deaths across the country, and a regional approach need to be taken to tackling them.

While I appreciate that drugs policy and legislation do not fall under the Minister’s departmental remit, I am happy to see her here, as the drugs-related deaths crisis is primarily a public health issue, and must be treated as such if we are to avoid repeating the same mistakes of the last 50 years.